Compare ODD & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ODD | BLFS |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 845.9M | 923.5M |
| IPO Year | 2022 | 2013 |
| Metric | ODD | BLFS |
|---|---|---|
| Price | $12.67 | $20.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $41.00 | $32.00 |
| AVG Volume (30 Days) | ★ 1.3M | 328.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | $22.92 | $17.82 |
| P/E Ratio | ★ $16.73 | $1,049.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $10.80 | $17.86 |
| 52 Week High | $79.18 | $29.57 |
| Indicator | ODD | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 34.25 | 43.77 |
| Support Level | $12.53 | $19.71 |
| Resistance Level | $15.73 | $20.47 |
| Average True Range (ATR) | 1.02 | 0.95 |
| MACD | -0.24 | -0.15 |
| Stochastic Oscillator | 7.93 | 17.85 |
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.